Cancer Stem Cells Market Share, Size & Trends Analysis Report By Mode Of Action (Stem Cell based Cancer Therapy, Targeted CSCs), By Cancer Forms (Breast Cancer, Bladder Cancer), By Region, And Segment Forecasts, 2023 - 2030
Cancer Stem Cells Market Growth & Trends
The global cancer stem cells market size is expected to reach USD 3.1 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 12.09% during the forecast period. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D for the development of effective and novel treatment methods based on stem cells.
Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market.
Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome.
Cancer Stem Cells Market Report Highlights
- Nutraceuticals dominated the market in 2022 with a revenue share of 60%, owing to the changing consumer preferences from chemical-based ingredients to organic and herbal ingredients in dietary supplements
- Online stores is anticipated to be the fastest-growing distribution channel segment over the forecast period, owing to the increase in penetration of e-commerce and the rising number of players offering their products online
- North America dominated the Cancer Stem Cells market for cannabidiol consumer health products, with a revenue share of around 70% in 2022.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Mode of action
- 1.1.2. Cancer forms
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Mode of action
- 2.2.2. Cancer forms
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Cancer Stem Cells Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.5. Cancer Stem Cells Market Analysis Tools
- 3.5.1. Industry Analysis - Porter’s
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic Landscape
- Chapter 4. Cancer Stem Cells: Mode of Action Estimates & Trend Analysis
- 4.1. Cancer Stem Cells Market: Key Takeaways
- 4.2. Cancer Stem Cells Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Targeted Cancerous Stem Cells (CSCs)
- 4.3.1. Targeted cancerous stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1. By anti-cancer stem cell therapeutics
- 4.3.1.1.1. By anti-cancer stem cell therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.1. Pathway inhibitors
- 4.3.1.1.1.1.1. Pathway inhibitors market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.1.1.1. WNT signaling pathway
- 4.3.1.1.1.1.1.1.1. WNT signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.1.1.2. Hedgehog signaling pathway
- 4.3.1.1.1.1.1.2.1. Hedgehog signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.1.1.3. Notch signaling pathway
- 4.3.1.1.1.1.1.3.1. Notch signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.1.1.4. Others
- 4.3.1.1.1.1.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.2. Surface marker-based
- 4.3.1.1.1.2.1. Surface marker-based market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.3. Immuno-evasion & targeting tumor microenvironment
- 4.3.1.1.1.3.1. Immuno-evasion & targeting tumor microenvironment market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.4. Nanoparticle-based therapies
- 4.3.1.1.1.4.1. Nanoparticle-based therapies market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1.1.5. Others
- 4.3.1.1.1.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.2. By-products
- 4.3.1.2.1. By products market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.2.1.1. Cell culturing
- 4.3.1.2.1.1.1. Cell culturing market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.2.1.2. Cell Separation
- 4.3.1.2.1.2.1. Cell separation market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.2.1.3. Cell Analysis
- 4.3.1.2.1.3.1. Cell analysis market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.2.1.4. Molecular analysis
- 4.3.1.2.1.4.1. Molecular analysis market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.2.1.5. Others
- 4.3.1.2.1.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Stem Cell-based Cancer Therapy
- 4.4.1. Stem cell-based cancer therapy market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.1. Autologous stem cell transplant
- 4.4.1.1.1. Autologous stem cell transplant market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.2. Allogeneic stem cell transplant
- 4.4.1.2.1. Allogeneic stem cell transplant market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 5. Cancer Stem Cells: Cancer Forms Estimates & Trend Analysis
- 5.1. Cancer Stem Cells Market: Key Takeaways
- 5.2. Cancer Stem Cells Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Breast Cancer
- 5.3.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Blood Cancer
- 5.4.1. Blood cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Lung Cancer
- 5.5.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Brain Cancer
- 5.6.1. Brain cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Colorectal Cancer
- 5.7.1. Colorectal cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.8. Pancreatic Cancer
- 5.8.1. Pancreatic cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.9. Bladder Cancer
- 5.9.1. Bladder cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.10. Liver Cancer
- 5.10.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.11. Other Cancer
- 5.11.1. Other cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 6. Cancer Stem Cells Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Cancer Stem Cells Market by Region: Key Marketplace Takeaway
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. Saudi Arabia
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Thermo Fisher Scientific, Inc.
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product Benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. AbbVie, Inc.
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Merck KGaA
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Bionomics
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Lonza
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Stemline Therapeutics, Inc.
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Miltenyi Biotec
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. PromoCell GmbH
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. MacroGenics, Inc.
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. FUJIFILM Irvine Scientific
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives
- 7.2.11. STEMCELL Technologies.
- 7.2.11.1. Company overview
- 7.2.11.2. Financial performance
- 7.2.11.3. Product benchmarking
- 7.2.11.4. Strategic initiatives
- 7.2.12. Sino Biological, Inc.
- 7.2.12.1. Company overview
- 7.2.12.2. Financial performance
- 7.2.12.3. Product benchmarking
- 7.2.12.4. Strategic initiatives
- 7.2.13. Lineage Cell Therapeutics, Inc.
- 7.2.13.1. Company overview
- 7.2.13.2. Financial performance
- 7.2.13.3. Product benchmarking
- 7.2.13.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook